Opinion | Treating Mild Coronavirus Cases Could Help Save Everyone

Opinion | Treating Mild Coronavirus Cases Could Help Save Everyone

The president’s decision is puzzling. And yet it does highlight the urgent need to devote more attention and resources to drugs that can prevent Covid-19 or stop mild cases from getting worse.

To date, about a dozen studies on therapies for Covid-19 have been published; all were conducted on hospitalized patients, typically with severe symptoms.

Treating people with no or mild symptoms of Covid-19 would benefit all. That’s why identifying and testing drugs that can accomplish this should become an absolute priority.

Richard Malley (@rickmalley) is a physician specializing in infectious diseases and a professor of Pediatrics at Harvard Medical School. Marc Lipsitch (@mlipsitch) is a professor in the Departments of Epidemiology and Immunology and Infectious Diseases at Harvard T.H. Chan School of Public Health, where he also directs the Center for Communicable Disease Dynamics.

The Times is committed to publishing a diversity of letters to the editor. We’d like to hear what you think about this or any of our articles. Here are some tips. And here’s our email: [email protected].

Follow The New York Times Opinion section on Facebook, Twitter (@NYTopinion) and Instagram.

Source link

Leave a Reply